Patents by Inventor Gary Park

Gary Park has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10889562
    Abstract: Aspects of the present disclosure include prodrugs of compounds that activate Nrf2. Such prodrugs find use in the treatment of autoimmune and inflammatory diseases and disorders, such as for example psoriasis and multiple sclerosis. Embodiments of the present disclosure also relate to pharmaceutical compositions that include these prodrugs, methods of using these prodrugs in the treatment of various diseases and disorders, processes for preparing these prodrugs and intermediates useful in these processes.
    Type: Grant
    Filed: August 12, 2020
    Date of Patent: January 12, 2021
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Jiaxin Yu, Beth Fernandez, Gary Park, Ihab Darwish
  • Publication number: 20200369644
    Abstract: Aspects of the present disclosure include prodrugs of compounds that activate Nrf2. Such prodrugs find use in the treatment of autoimmune and inflammatory diseases and disorders, such as for example psoriasis and multiple sclerosis. Embodiments of the present disclosure also relate to pharmaceutical compositions that include these prodrugs, methods of using these prodrugs in the treatment of various diseases and disorders, processes for preparing these prodrugs and intermediates useful in these processes.
    Type: Application
    Filed: August 12, 2020
    Publication date: November 26, 2020
    Inventors: Jiaxin Yu, Beth Fernandez, Gary Park, Ihab Darwish
  • Patent number: 10784622
    Abstract: An adjustable spacer is provided. The adjustable spacer includes a first body having a first retention member for securing or retaining the first body to a support member and a second body having a tapered cross-section. The second body is positionable along a surface of the first body to adjust a thickness across a combination of the first body and the second body, and the first body has a second retention member for retaining the second body to the first body.
    Type: Grant
    Filed: March 4, 2019
    Date of Patent: September 22, 2020
    Assignee: Arista Networks, Inc.
    Inventors: Robert Wilcox, Richard Hibbs, Youngbae Park, Gary Myers, Matthew Gawlowski, Rui Jia
  • Patent number: 10774066
    Abstract: Aspects of the present disclosure include prodrugs of compounds that activate Nrf2. Such prodrugs find use in the treatment of autoimmune and inflammatory diseases and disorders, such as for example psoriasis and multiple sclerosis. Embodiments of the present disclosure also relate to pharmaceutical compositions that include these prodrugs, methods of using these prodrugs in the treatment of various diseases and disorders, processes for preparing these prodrugs and intermediates useful in these processes.
    Type: Grant
    Filed: May 14, 2019
    Date of Patent: September 15, 2020
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Jiaxin Yu, Beth Fernandez, Gary Park, Ihab Darwish
  • Publication number: 20200287325
    Abstract: An adjustable spacer is provided. The adjustable spacer includes a first body having a first retention member for securing or retaining the first body to a support member and a second body having a tapered cross-section. The second body is positionable along a surface of the first body to adjust a thickness across a combination of the first body and the second body, and the first body has a second retention member for retaining the second body to the first body.
    Type: Application
    Filed: March 4, 2019
    Publication date: September 10, 2020
    Inventors: Robert Wilcox, Richard Hibbs, Youngbae Park, Gary Myers, Matthew Gawlowski, Rui Jia
  • Publication number: 20200268747
    Abstract: Extended release, abuse deterrent dosage forms comprising crush-resistant controlled-release particles that provide abuse deterrent properties to the dosage forms. The crush-resistant controlled-release particles, which comprise plastic/elastic polymers and at least one active pharmaceutical ingredient (API) or a pharmaceutically acceptable salt thereof, are prepared by a hot melt extrusion process.
    Type: Application
    Filed: March 13, 2020
    Publication date: August 27, 2020
    Inventors: Jonathan Gaik, Jaehan Park, Ryan Lathrop, Gary Nichols, John Schallom
  • Publication number: 20200251324
    Abstract: A product having at least one plasma lamp that includes plates that are approximately parallel, with at least one array of microcavities formed in a surface of at least one plate. When desirable, the plates are separated a fixed distance by spacers with at least one spacer being placed near the plate's edge to form a hermetic seal therewith. A gas makes contact with the microcavity array. Electrodes capable of delivering a time-varying voltage are located such that the application of the time-varying voltage interacts with the gas to form a glow discharge plasma in the microcavities and the fixed volume between the plates. The glow discharge plasma efficiently and uniformly emits radiation that is predominantly in the UV/VUV spectral range with at least a portion of the radiation being emitted from the plasma lamp.
    Type: Application
    Filed: April 16, 2020
    Publication date: August 6, 2020
    Inventors: Sung-Jin Park, Cyrus M. Herring, James Gary Eden
  • Patent number: 10712862
    Abstract: An electronic device includes a foldable touch screen having first and second portions and a bendable intermediate portion connecting the first portion to the second portion. The foldable touch screen has a capacitive touch matrix therein. A touch screen controller acquires touch data from the capacitive touch matrix, calculates strength values of nodes of the capacitive touch matrix based upon the acquired touch data, calculates a first value, the first value being an average strength of nodes of the capacitive touch matrix located in the first portion of the foldable touch screen, calculates a second value, the second value being an average strength of nodes of the capacitive touch matrix located in the second portion of the foldable touch screen, and determines that the foldable touch screen is in a closed position based upon the first value and the second value both being greater than a first given strength value.
    Type: Grant
    Filed: March 22, 2019
    Date of Patent: July 14, 2020
    Assignee: STMicroelectronics Asia Pacific Pte Ltd
    Inventors: Jm Kang, Alex Hong, Sj Koo, Tim Kim, Shaun Park, Gary Lee
  • Patent number: 10658170
    Abstract: A plasma lamp includes plates that are approximately parallel, with at least one array of microcavities formed in a surface of at least one plate. When desirable, the plates are separated a fixed distance by spacers with at least one spacer being placed near the plate's edge to form a hermetic seal therewith. A gas makes contact with the microcavity array. Electrodes capable of delivering a time-varying voltage are located on the surface of each plate. At least one electrode is located on an exterior surface of at least one interior plate. Optionally, protective windows may be placed over the electrodes. The application of the time-varying voltage interacts with the gas to form a glow discharge plasma in the microcavities and the fixed volume between the plates (when present). The glow discharge plasma efficiently and uniformly emits UV/VUV radiation over the entire surface of the lamp.
    Type: Grant
    Filed: June 27, 2016
    Date of Patent: May 19, 2020
    Assignee: Eden Park Illumination
    Inventors: Sung-Jin Park, Cyrus M. Herring, James Gary Eden
  • Patent number: 10625235
    Abstract: A method for generating a hybrid reaction flows feedstock gas that is also a plasma medium through microchannels. Plasma is generated with the plasma medium via excitation with a time-varying voltage. UV or VUV emissions are generated at a wavelength selected to break a chemical bond in the feedstock gas. The UV or VUV emissions are directed into the microchannels to interact with the plasma medium and generate a reaction product from the plasma medium. A hybrid reactor device includes a microchannel plasma array having inlets and outlets for respectively flowing gas feedstock into and reaction product out of the microchannel plasma array. A UV or VUV emission lamp has its emissions directed into microchannels of the microchannel plasma array. Electrodes ignite plasma in the microchannels and stimulating the UV or VUV emission lamp to generate UV or VUV emissions. One common or plural phased time-varying voltage sources drive the plasma array and the UV or VUV emission lamp.
    Type: Grant
    Filed: October 10, 2017
    Date of Patent: April 21, 2020
    Assignee: The Board of Trustees of the University of Illinois
    Inventors: James Gary Eden, Sung-Jin Park, Charles Shin, Andrey Mironov
  • Patent number: 10624888
    Abstract: Extended release, abuse deterrent dosage forms comprising crush-resistant controlled-release particles that provide abuse deterrent properties to the dosage forms. The crush-resistant controlled-release particles, which comprise plastic/elastic polymers and at least one active pharmaceutical ingredient (API) or a pharmaceutically acceptable salt thereof, are prepared by a hot melt extrusion process.
    Type: Grant
    Filed: March 21, 2017
    Date of Patent: April 21, 2020
    Assignee: SpecGX LLC
    Inventors: Jonathan Gaik, Jaehan Park, Ryan Lathrop, Gary Nichols, John Schallom
  • Publication number: 20200097957
    Abstract: Turning now to the drawings, systems and methods for transferring funds in accordance with embodiments of the invention are illustrated. In one embodiment, a method for conducting peer-to-peer transfers includes obtaining a cash-out request data using a fund transfer server system, wherein the cash-out request data includes target account data and fund data, the target account data includes metadata identifying a consumer account and specifies an account to which funds will be provided, and the fund data describes the funds to be provided in response to redeeming the cash-out request, generating a cash-out code based on cash-out request data using the fund transfer server system, providing the cash-out code using the fund transfer server system, obtaining cash-out code redemption data using the fund transfer server system, wherein the cash-out code redemption data identifies the provided cash-out code, and transmitting a request to provide the funds described by the fund data.
    Type: Application
    Filed: September 30, 2019
    Publication date: March 26, 2020
    Applicant: Green Dot Corporation
    Inventors: Gary Taylor Driggs, David Gullett, Helena Mao, Calvin Park, Vijay Ramamurthy, Jeffrey Wang
  • Patent number: 10548210
    Abstract: Non-disperse, periodic microplasmas are generated in a volume lacking interfering structures, such as electrodes, to enable photonic interaction between incident electromagnetic energy and the non-disperse, periodic microplasmas. Preferred embodiments leverage 1D, 2D, 3D and super 3D non-disperse, periodic microplasmas. In preferred embodiments, the non-disperse, periodic microplasmas are elongate columnar microplasmas. In other embodiments, the non-disperse, periodic microplasmas are discrete isolated microplasmas. The photonic properties can change by selectively activating groups of the periodic microplasmas.
    Type: Grant
    Filed: September 28, 2016
    Date of Patent: January 28, 2020
    Assignee: The Board of Trustees of the University of Illinois
    Inventors: J. Gary Eden, Paul V. Braun, Sung-Jin Park, Hee Jun Yang, Peng Sun, Runyu Zhang
  • Publication number: 20190367472
    Abstract: Aspects of the present disclosure include prodrugs of compounds that activate Nrf2. Such prodrugs find use in the treatment of autoimmune and inflammatory diseases and disorders, such as for example psoriasis and multiple sclerosis. Embodiments of the present disclosure also relate to pharmaceutical compositions that include these prodrugs, methods of using these prodrugs in the treatment of various diseases and disorders, processes for preparing these prodrugs and intermediates useful in these processes.
    Type: Application
    Filed: May 14, 2019
    Publication date: December 5, 2019
    Inventors: Jiaxin Yu, Beth Fernandez, Gary Park, Ihab Darwish
  • Patent number: 10430788
    Abstract: Turning now to the drawings, systems and methods for transferring funds in accordance with embodiments of the invention are illustrated. In one embodiment, a method for conducting peer-to-peer transfers includes obtaining a cash-out request data using a fund transfer server system, wherein the cash-out request data includes target account data and fund data, the target account data includes metadata identifying a consumer account and specifies an account to which funds will be provided, and the fund data describes the funds to be provided in response to redeeming the cash-out request, generating a cash-out code based on cash-out request data using the fund transfer server system, providing the cash-out code using the fund transfer server system, obtaining cash-out code redemption data using the fund transfer server system, wherein the cash-out code redemption data identifies the provided cash-out code, and transmitting a request to provide the funds described by the fund data.
    Type: Grant
    Filed: August 6, 2015
    Date of Patent: October 1, 2019
    Assignee: Green Dot Corporation
    Inventors: Gary Taylor Driggs, David Gullett, Helena Mao, Calvin Park, Vijay Ramamurthy, Jeffrey Wang
  • Publication number: 20190224155
    Abstract: Embodiments of the disclosure are drawn to an enteral feeding device for hydrolyzing triglycerides in a nutritional formula. The device may include a body housing a chamber, an inlet configured to fluidly couple with a source of nutritional formula, and an outlet configured to fluidly couple with an enteral feeding tube. The device may include a headspace and a plurality of particles contained within the chamber, wherein the lipase is covalently bonded to the plurality of particles. The device may include an inlet filter located between the inlet and the chamber, wherein the inlet filter contains a first plurality of openings, and an outlet filter located between the chamber and the outlet, wherein the outlet filter has a second plurality of openings smaller than the plurality of particles.
    Type: Application
    Filed: February 27, 2019
    Publication date: July 25, 2019
    Applicant: Alcresta Therapeutics, Inc.
    Inventors: Robert Gallotto, Greta L. Loring, Kenneth Gary, Edward S. Park, David J. Brown, Willem Robert Klaas Schoevaart, Michiel Christian Alexander van Vliet
  • Publication number: 20190214244
    Abstract: A plasma lamp includes plates that are approximately parallel, with at least one array of microcavities formed in a surface of at least one plate. When desirable, the plates are separated a fixed distance by spacers with at least one spacer being placed near the plate's edge to form a hermetic seal therewith. A gas makes contact with the microcavity array. Electrodes capable of delivering a time-varying voltage are located on the surface of each plate. At least one electrode is located on an exterior surface of at least one interior plate. Optionally, protective windows may be placed over the electrodes. The application of the time-varying voltage interacts with the gas to form a glow discharge plasma in the microcavities and the fixed volume between the plates (when present). The glow discharge plasma efficiently and uniformly emits UV/VUV radiation over the entire surface of the lamp.
    Type: Application
    Filed: June 27, 2016
    Publication date: July 11, 2019
    Inventors: Sung-Jin Park, Cyrus M. Herring, James Gary Eden
  • Publication number: 20120041884
    Abstract: A method and system for processing an automotive warranty claim include capturing at least one digital image of a vehicle-related customer concern with a digital camera device. A barcode identifying the vehicle is scanned with a barcode scanning device. Upon establishing operable communication between a first computer and the digital camera device and the barcode scanning device, respectively, the at least one digital image and the barcode information are automatically downloaded into the first computer. Dialog is input into the first computer requesting warranty coverage for the customer concern. A claimset comprising the digital images, barcode and request for warranty coverage is transmitted to a second computer via a communication network. The claimset is reviewed at the second computer to decide whether warranty coverage will be provided. The claimset is updated with the decision and transmitted back to the first computer via the communication network.
    Type: Application
    Filed: October 28, 2011
    Publication date: February 16, 2012
    Applicant: FORD MOTOR COMPANY
    Inventors: William T. Rowse, Barry M. Inman, Debra L. Mayberry, David Gary Park, Henry Thomas Ubik, Paul W. Mashni, Robert P. Jackson
  • Patent number: 7877469
    Abstract: A system is provided that includes a manager device that executes a Simple Network Management Protocol (SNMP) manager. The system also includes an agent device coupled to the manager device. The agent device executes a SNMP agent that selectively provides access to managed data. The SNMP manager enables a user to issue a login command. The SNMP agent processes the login command and, if the user is authenticated, allows the user to access the managed data using a session identifier.
    Type: Grant
    Filed: February 1, 2006
    Date of Patent: January 25, 2011
    Assignee: Samsung Electronics Co., Ltd.
    Inventors: Scott Fang, Kong Posh Bhat, Gary Parks
  • Patent number: 7498353
    Abstract: The present invention relates to prodrugs and compositions thereof useful for treating or preventing Hepatitis C virus (HCV) infections. In particular, the present invention relates to prodrugs of substituted diphenyl-, diheteroaryl- and mixed phenyl heteroaryl substituted five-membered heterocycle compounds, compositions comprising the compounds and the use of such compounds and compositions to inhibit HCV replication and/or proliferation as a therapeutic approach towards the treatment and/or prevention of HCV infections in humans and animals.
    Type: Grant
    Filed: May 2, 2006
    Date of Patent: March 3, 2009
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Rajinder Singh, Dane Goff, Ihab S. Darwish, Rao S. S. Kolluri, Henry Lu, Gary Park